STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 98 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $130,000 | +5.7% | 26,780 | +132.2% | 0.00% | 0.0% |
| Q4 2019 | $123,000 | +1437.5% | 11,534 | +1413.6% | 0.00% | – |
| Q3 2019 | $8,000 | -83.3% | 762 | -75.7% | 0.00% | – |
| Q2 2019 | $48,000 | +433.3% | 3,134 | +342.7% | 0.00% | – |
| Q1 2019 | $9,000 | -89.3% | 708 | -86.1% | 0.00% | -100.0% |
| Q3 2018 | $84,000 | +31.2% | 5,088 | +28.3% | 0.00% | 0.0% |
| Q2 2018 | $64,000 | +190.9% | 3,966 | +186.6% | 0.00% | – |
| Q4 2017 | $22,000 | +46.7% | 1,384 | +5.7% | 0.00% | – |
| Q3 2017 | $15,000 | -46.4% | 1,309 | -60.0% | 0.00% | – |
| Q1 2017 | $28,000 | -42.9% | 3,274 | -58.0% | 0.00% | -100.0% |
| Q4 2015 | $49,000 | -44.3% | 7,797 | -22.0% | 0.00% | 0.0% |
| Q3 2015 | $88,000 | – | 9,997 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 762,941 | $7,248,000 | 7.29% |
| NEXTHERA CAPITAL LP | 711,558 | $6,760,000 | 2.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 585,930 | $4,366,000 | 2.71% |
| Consonance Capital Management LP | 1,155,793 | $10,980,000 | 0.81% |
| Pier Capital, LLC | 423,667 | $4,025,000 | 0.80% |
| KNOTT DAVID M | 155,795 | $1,480,000 | 0.70% |
| Eventide Asset Management | 1,086,400 | $10,321,000 | 0.46% |
| Empire Life Investments Inc. | 373,863 | $3,552,000 | 0.32% |
| Telemetry Investments, L.L.C. | 41,588 | $395,000 | 0.25% |
| Polar Capital LLP | 2,302,666 | $21,875,000 | 0.23% |